Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Evaluation of ADG20 for the Prevention of COVID-19

ClinicalTrials.gov ID: NCT04859517

Public ClinicalTrials.gov record NCT04859517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 8:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This placebo-controlled study is intended to evaluate ADG20's safety and ability to prevent COVID-19 infection.

Study identification

NCT ID
NCT04859517
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Invivyd, Inc.
Industry
Enrollment
2,582 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2021
Primary completion
Nov 3, 2022
Completion
Nov 3, 2022
Last update posted
Aug 19, 2024

2021 – 2022

United States locations

U.S. sites
66
U.S. states
25
U.S. cities
63
Facility City State ZIP Site status
Invivyd Investigative Site Birmingham Alabama 35209
Invivyd Investigative Site Tucson Arizona 85745
Invivyd Investigative Site Fayetteville Arkansas 72701
Invivyd Investigative Site North Little Rock Arkansas 72223
Invivyd Investigative Site Banning California 92220
Invivyd Investigative Site Chula Vista California 91911
Invivyd Investigative Site Culver City California 90230
Invivyd Investigative Site Escondido California 92025
Invivyd Investigative Site Fullerton California 92835
Invivyd Investigative Site Long Beach California 90806
Invivyd Investigative Site Los Angeles California 90036
Invivyd Investigative Site Modesto California 95350
Invivyd Investigative Site Palm Springs California 92262
Invivyd Investigative Site San Diego California 92103
Invivyd Investigative Site Clearwater Florida 33756
Invivyd Investigative Site Edgewater Florida 32132
Invivyd Investigative Site Hialeah Florida 33012
Invivyd Investigative Site Miami Florida 33155
Invivyd Investigative Site Miami Florida 33176
Invivyd Investigative Site Miami Florida 33186
Invivyd Investigative Site Mt. Dora Florida 32757
Invivyd Investigative Site North Miami Beach Florida 33169
Invivyd Investigative Site Ormond Beach Florida 32174
Invivyd Investigative Site Pembroke Pines Florida 33026
Invivyd Investigative Site Sunrise Florida 33325
Invivyd Investigative Site Tampa Florida 33603
Invivyd Investigative Site The Villages Florida 32159
Invivyd Investigative Site West Palm Beach Florida 33409
Invivyd Investigative Site Hinesville Georgia 31313
Invivyd Investigative Site Lawrenceville Georgia 30044
Invivyd Investigative Site Pearl City Hawaii 96782
Invivyd Investigative Site Chicago Illinois 60607
Invivyd Investigative Site Oak Brook Illinois 60523
Invivyd Investigative Site Owensboro Kentucky 42303
Invivyd Investigative Site Marrero Louisiana 70072
Invivyd Investigative Site New Orleans Louisiana 70118
Invivyd Investigative Site Rockville Maryland 20855
Invivyd Investigative Site Burlington Massachusetts 01803
Invivyd Investigative Site Caro Michigan 48723
Invivyd Investigative Site Grosse Pointe Woods Michigan 48236
Invivyd Investigative Site Missoula Montana 59808
Invivyd Investigative Site Albuquerque New Mexico 87102
Invivyd Investigative Site New York New York 11201
Invivyd Investigative Site Charlotte North Carolina 28208
Invivyd Investigative Site Shelby North Carolina 28150
Invivyd Investigative Site Beachwood Ohio 44122
Invivyd Investigative Site Cincinnati Ohio 54242
Invivyd Investigative Site Dresden Ohio 43821
Invivyd Investigative Site Middleburg Heights Ohio 44130
Invivyd Investigative Site Yukon Oklahoma 73099
Invivyd Investigative Site Medford Oregon 97504
Invivyd Investigative Site West Columbia South Carolina 29169
Invivyd Investigative Site Jackson Tennessee 38305
Invivyd Investigative Site Milan Tennessee 38358
Invivyd Investigative Site Nashville Tennessee 37203
Invivyd Investigative Site Beaumont Texas 77706
Invivyd Investigative Site College Station Texas 77845
Invivyd Investigative Site Corpus Christi Texas 78412
Invivyd Investigative Site Houston Texas 77022
Invivyd Investigative Site Houston Texas 77087
Invivyd Investigative Site Hurst Texas 76054
Invivyd Investigative Site Mesquite Texas 75149
Invivyd Investigative Site Sugar Land Texas 77479
Invivyd Investigative Site St. George Utah 84790
Invivyd Investigative Site West Jordan Utah 84088
Invivyd Investigative Site Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

Recently updated COVID-19 trials

Other public records listing COVID-19. Sorted by last update posted; newest first. Not a recommendation.

All COVID-19 trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04859517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2024 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04859517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →